Company: INDP
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001641172-25-014978
Chunk: 3

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 3
---
 the Company during regular business hours for a period of at least ten days prior to
the Special Meeting for any purpose germane to the meeting. The Special Meeting may be continued, postponed, or adjourned from time to
time without notice other than by announcement at the Special Meeting.

Please note that in order to gain admission to
the site of our Special Meeting, all attendees will need to present a photo identification card and have their name previously provided
to building security. As such, in order to facilitate your attendance at the Special Meeting, we strongly encourage you to advise Nir
Sassi by email at or phone at (646) 427-2727 if you plan to attend the meeting prior to 5:00 p.m., Eastern
time, on July 24, 2025, so that we can timely provide your name to building security. In the event that you do not advise us ahead of
time that you will be attending the Special Meeting, we encourage you to arrive at the meeting no later than 9:00 a.m., Eastern time,
in order to ensure that you are able to pass through security prior to the start of the meeting. We currently intend to hold the meeting
in person. However, if we determine that a change to a virtual meeting format is advisable or required, an announcement of such change
will be made on the Investors page of our website at https://indaptusrx.com and in a Current Report on Form 8-K as promptly as practicable.
We encourage you to check that website one week prior to the meeting date if you are planning to attend the Special Meeting. We ask that
each stockholder evaluate the relative benefits of in-person attendance at the Special Meeting and take advantage of the ability to vote
by proxy or to provide voting instructions in accordance with the voting materials that have been provided to you.

It is important that your shares be represented regardless of the number of shares you may hold. Whether or not you plan to attend the Special Meeting in person, we urge you to vote your shares via the toll-free telephone number or over the Internet, as described in the enclosed materials. If you received a copy of the proxy card by mail, you may sign, date and mail the proxy card in the enclosed return envelope. Promptly voting your shares will ensure the presence of a quorum at the Special Meeting and will save us the expense of further solicitation. Submitting your proxy now will not prevent you from voting your shares at the Special Meeting if you desire to